Top Buy
Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.55 | €35.99 | 17.791% |
Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 0 | 0 | €49.85 | €57.50 | 15.346% |
Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.57 | €3.70 | 135.669% |
Compugen Ltd. | 3 | 2 | 1 | 0 | €2.01 | €3.67 | 82.813% |
Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €44.27 | €70.00 | 58.121% |
Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.22 | €19.86 | 219.371% |
Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.52 | €5.00 | 10.619% |
AC Immune Ltd | 4 | 0 | 0 | 0 | €2.15 | €12.27 | 472.196% |
Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.75 | €4.39 | 150.645% |
Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €2.10 | €12.09 | 475.686% |
Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.16 | €5.36 | 69.759% |
Anika Therapeutics | 4 | 0 | 0 | 0 | €25.60 | €26.58 | 3.834% |
Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
Sanofi S.A. | 4 | 0 | 0 | 0 | €91.29 | €99.50 | 8.993% |
Sartorius AG VZO | 4 | 0 | 0 | 0 | €282.70 | - | - |
Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
Fresenius SE & Co. KGaA | 4 | 0 | 1 | 0 | €27.85 | - | - |
Cerus Corp. | 4 | 0 | 2 | 0 | €1.52 | €3.26 | 114.089% |
Chimerix Inc. | 4 | 1 | 0 | 0 | €0.89 | €5.51 | 520.315% |
Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.45 | €8.50 | 0.651% |
Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €127.10 | €144.44 | 13.646% |
GSK plc ADR | 4 | 0 | 0 | 0 | €40.40 | - | - |
Fresenius Medical Care AG & Co KGaA ADR | 4 | 1 | 2 | 0 | €20.20 | €21.00 | 3.960% |